Victoria, BC

Join us on Vancouver Island in majestic Victoria, BC for 3 days of cannabis cultivation, psychedelics and extraction.

June 20-22, 2022

Niagara Falls, ON

Join us in spectacluar Niagara Falls, ON for 3 days of cannabis cultivation, psychedelics and extraction.

September 12-14, 2022

Grow Up Awards Gala

Annual Grow Up Industry Awards. Come celebrate the innovation and sucess in the cannabis growing industry.

September 12, 2022, Niagara Falls

420 with CNW — New App Can Reveal Potential Interactions Between Medications, Cannabinoids

May 2, 2022 | Cannabis News Wire, Media Partners

This post is presented by our media partner Cannabis News Wire

View the original article here.

image

A newly developed application can enable pharmacists as well as other medical professionals to enhance patient safety. This can be achieved by using the app to predict how cannabinoids, such as those found in medical cannabis, may interact with any other medications that a patient is taking.

Researchers at Penn State University developed the app, called CANNabinoid Drug Interaction Review (CANN-DIR). The app works by evaluating how various cannabinoids, including THC and CBD, found in different over-the-counter or prescription medical cannabis products interact with the other medicines that a patient is taking. The app has a database containing the common drugs that people access in hospitals and pharmacies. A healthcare worker or other professional simply inputs the cannabis compounds found in a product and then selects from a list of drugs to see what form any drug-on-drug interactions could take place.

For example, one may find that certain cannabinoids may slow down or accelerate the metabolism of a given active ingredient in a prescription drug. In such a case, the healthcare provider would tweak the dosage of the said drug in order to meet the intended therapeutic goals while avoiding any adverse events resulting from the drug-on-drug interaction.

Kent Vrana, who led the research team behind this app, explains that it is crucial that people realize that CBD, THC and other cannabis compounds may affect the rate at which other drugs are broken down or metabolized in the body. He adds that by using the app, it is possible to have a meaningful conversation with a patient regarding possible interactions between a given combination of cannabinoids and the conventional drugs being used by the patient.

This app has the potential to provide a meaningful way in which cannabinoids can be used safely alongside other medications. It can also help to address the reasons why some professionals in the mainstream medical field are hesitant or opposed to medical marijuana and  CBD products that the public can readily access from retail stores, medical cannabis outlets or even the black market. This is because the app avails science-backed information to address the concerns of the healthcare professional.

The research team was composed of people from the university’s medical school and a team of computer science professionals at the same university. The first version of the app went live on March 22, 2022, and the team is now focused on making a second reiteration of the app, which they hope will rate higher in terms of its user friendliness for caregivers and patients themselves.

This app will hopefully give patients the reassurance they need that using cannabis products from licensed suppliers such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) can be safe and helpful if necessary precautions are taken, such as talking to one’s doctor beforehand.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CNW420 is part of the InvestorBrandNetwork.

This post was originally published by our media partner here.

UPCOMING EVENTS

O’Cannabiz – June 1-3, 2022
International Convention Centre, Toronto ON

Grow Up – June 20-22, 2022
Victoria Convention Centre, Victoria ON

Grow Up – September 12-14, 2022
Niagara Falls Convention Centre, ON

News from Grow Up Media partners